In IPF, there is evidence that epithelial cell injury results in release of active TGF-β, which can activate ECs, causing an imbalance of angiostatic and angiogenic mediators including VEGF, resulting in abnormal EC proliferation and apoptosis (31) (Figure 2). This evidence concerns the gene TGFB1 and idiopathic pulmonary fibrosis.